Vivex to Serve As Platinum Sponsor for 13th World Stem Cell Summit


(MENAFNEditorial) MIAMI, Jan. 22, 2018 /PRNewswire/ --Vivex Biomedical, Inc. is proud to announce their platinum sponsorship of the 13th World Stem Cell Summit (WSCS). The summit will take place January 22-26, 2018 at the Hyatt Regency Miami. "The 2018 World Stem Cell Summit is the global, super-ecosystem event, trans-disciplinary in scope," explained Bernard Siegel, Founder of the WSCS and Executive Director of the RMF.

In addition to sponsoring WSCS, two of Vivex's most distinguished members will be presenting to fellow attendees and participants:

Advancing the exosome; extracellular vesicle into the mainstream
January 25, 11:30am – 1:15pm
H. Thomas Temple, MD; Chief Medical Officer
Tim Ganey, PhD; Chief Scientific Officer

President and CEO Tracy S. Anderson stated, "Vivex is excited and honored to be part of such a prestigious and innovative event. We look forward to engaging with members of our field, working with other leaders in the industry, and discussing what is next for regenerative medicine."

About Vivex Biomedical, Inc.
Vivex Biomedical, Inc. is a regenerative biologics company, dedicated to creating new standards in patient care. Since 2014, Vivex and UMTB (founded 1970) have strived for methods to translate creative collaborations into treatments for real problems. In collaboration with multiple partners, Vivex is on the cutting edge of scientific development. Translating innovation into treatments for real problems further expands surgical options. All research and development is focused on making strides in the field of musculoskeletal regenerative medicine, with major areas of investigation including: cartilage, bone, and skin. Innovative vision provides a platform that assists in the regeneration of all these tissue types in a personalized but scalable transplantation model.

About World Stem Cell Summit
Produced by Regenerative Medicine Foundation (RMF), this original, translation-focused, international and partnering conference is expecting 1,000 attendees from over 30 countries in the world, more than 210 participating organizations, and 100+ speakers.

For more information, please visit .

View original content with multimedia:

SOURCE Vivex Biomedical, Inc.

MENAFN2201201800701241ID1096379049


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.